Different mechanisms of action of beta2-adrenergic receptor agonists: A comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro

European Journal of Medical Research

Volumn 9, Issue 7, 2004, Pages 365-370

  Juergens, Uwe ^a   Stober M ^a   Libertus, H ^b   Darlath, W ^c   Gilliessen, A ^d   Vetter, H ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Viatris Inc   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d Robert Koch Klinik   (Germany)

Author keywords

Asthma; CAMP; Fenoterol; Leukotriene B4; Reproterol; Salbutamol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; DRUG DERIVATIVE; FENOTEROL; ISOBUTYLMETHYLXANTHINE; LEUKOTRIENE B4; ORCIPRENALINE; PHOSPHODIESTERASE INHIBITOR; REPROTEROL; SALBUTAMOL; THEOPHYLLINE;

ADULT; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; HUMAN; METABOLISM; MONOCYTE;

1-METHYL-3-ISOBUTYLXANTHINE; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; CELLS, CULTURED; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FENOTEROL; HUMANS; LEUKOTRIENE B4; MONOCYTES; ORCIPRENALINE; PHOSPHODIESTERASE INHIBITORS; RECEPTORS, ADRENERGIC, BETA-2; THEOPHYLLINE;

EID: 16644366281     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barnes PJ, Pauwels R, O'Byrne PM, editors (1997) Beta2-Agonists in Asthma Treatment New York: Marcel Dekker, Inc. 3, Effect of beta-agonists on airway effector cells. p. 35-66.
2. Berg A, Albrecht B, Darlath W, Voß HW, Berdel D (2002) Intraindividual, randomised, double-blind comparison between sodium cromoglycate and reproterol to assess the protective effect of the single drugs and their combination in children with exercise-induced asthma. Allergologie 25 (11): 557-564.
3. Boyum A (1983) Isolation of human monocytes with Ny-codenz, a new non-ionic iodinated gradient medium. Scand J Immunol 17: 429-436
4. Church NK Hiroi J (1987) Inhition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 90 (2): 421-429.
5. Dasi FJ, Ortiz JI, Cortijo J, Mordillo, FJ (2000) Histamine up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils. Inflamm Res 49(11):600-609.
6. Ellis KE, Mistry R, Boyle JP, Challiss RA. Correlation of cyclic AMP accumulation and relaxant actions of salmeterol and salbutimol in bovine tracheal smooth muscle (1995) Br J Pharmacol 116(5):2510-2516.
7. Fairfax AJ, Rehahn M, Jones D, O'Malley B (1984) Comparison between the effects of inhaled isoprenaline and fenoterol on plasma cyclic AMP and heart rate in normal subjects. Br J Chin Pharmacol 17(2):165-170.
8. Habersang S, Leuschner F, von Schlichtegroll A (107 [Toxicological investigation of reproterol (author's transl)]. Arzneimittelforschung 27 (12): 45-52.
9. Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL. (1992) Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge. J Allergy Chn Immunol 90: 636-645.
10. Juergens UR, Stöber M, Vetter H (1999) Reproterol - a monomolecular combination of orciprenaline and theophyfline: novel aspects of its mode of 'action in asthma. Respiration 66: 220-224,
11. Kirino Y, Mio M, Fujii Y, Kamel C (2003) Role of Src in hypersensitization to phosphodiesterase inhibitors in beta2-adrenoceptor-desensitized eosinophiles. Methods Find Exp Cli Pharmacol 25(7):517-520.
12. Liggett SB (19819) Identification and characterization of a homogeneous population of beta 2- adrenergic receptors on human alveolar macrophages. Am Rev Respir Dis 139(2):552-555.
13. Lipworth BJ, Clark RA, Dhillon DP, Brown RA, McDevitt DG (1988) Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. Br J Clin Pharmacol 26(5):527-533.
14. Madelian V, La Vigne E (1996) Rapid regulation of a cyclic AMP-specific pbosphodiesterase (PDE IV) by forskolin and isoproterenol in LRM55 astroglial cells. Biochem Pharmacol 28;51(12):1739-1747.
15. Manning CD, McLaughlin MM, Livi GP, Cieslinski LB, Torphy TJ, Barnette MS (1996) Prolonged beta adrenoceptor stimulation up-regulates cAMP phospbodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B. J Pharmacol Exp Ther 276:810-818.
16. Maurice DH (1998) Cyclic nucleodde-mediated regulation of vascular smooth muscle cell cyclic nude.otide phosphodiesterase activity. Selective effect of cyclic AMP. Cell Biochem Biophys 29(1-2):35-47.
17. Mio M, Kirino Y, Kamei C (2000) Desensitization of beta2-adrenoceptor and hypersensitization to phosphodiesterase inhibitors elicited by beta2-agonists in guinea pig eosinophils. J Allergy Clin Immunol 106 (5):896-903.
18. Morgan AJ, Murray KJ, Challiss RA (1993) Comparison of the effect of isobutylmethylxanthine and phosphodiesterase-selective inhibitors on cAMP levels in SH-SY5Y neuroblastoma cells. Biochem Pharmacol 45(12):2373-2380.
19. National Heart, L.a.B.I. and WHO (1995) Global strategy for asthma management and prevention NHLBI/WHO Workshop. National Institutes of Health 95-3659: 40.
20. Nyberg L. Pauwels R, O'Byrne PM, editors (1997) Beta2-Agonists in Asthma Treatment. New York: Marcel Dekker, Inc. 5, Pharmacokinetics of beta-2-adrenoceptor-stimulating drugs. p. 87-130.
21. Oki N, Takahashi ST, Hidaka H, Conti M (2000) Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of PDE4D3 phosphodiesterase activation. J Biol Chem 275:10831-10837.
22. Pacheco Y, Hosni R, Chabannes B, Gormand F, Moliere P, Grosclaude M, Piperno D, Lagarde M, Perrin-Fayolle M (1992) Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy. Eur J Clin Invest 22(11):732-739.
23. Tachibana A, Kato M, Kimura H, Fujiu T, Suzuki M, Morikawa A (2002) Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions. Clin Exp Immunol 130 (3):415-423.
24. Torphy TJ, Zhou HL, Cieslinski LB (1992) Stimulation of beta adrenoceptors in a human monocytic cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity. J Pharmacol Exp Ther 263 (3):1195-1205.
25. Torphy TJ (1998) Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 157 (2): 351-370.
26. Verghese MW, McConnell RT, Lenhard JM, Hamacher L, Jin SL (1995) Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodieesterase type 4) isozymes in human monocytic cells. Mol Pharmacol 47(6):1164-1171.
27. Zetterlund A, Linden M, Larsson K (1998) Effects of beta2-agonists and budesonide on interleukin-lbeta and leukotriene B4 secretion: studies of human monocytes and alveolar macrophages. J Asthma 35(7):565-573.